Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.
Minarik J, Radocha J, Jungova A, Straub J, Jelinek T, Pika T, Pour L, Pavlicek P, Harvanova L, Pospisilova L, Krhovska P, Novakova D, Jindra P, Spicka I, Plonkova H, Stork M, Bacovsky J, Maisnar V, Hajek R. Minarik J, et al. Among authors: hajek r. Cancers (Basel). 2022 Oct 21;14(20):5165. doi: 10.3390/cancers14205165. Cancers (Basel). 2022. PMID: 36291949 Free PMC article.
Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech Registry Data.
Maisnar V, Pour L, Spicka I, Jelinek T, Minarik J, Jungova A, Stork M, Straub J, Radocha J, Pika T, Pospisilova L, Nair S, Kunovszki P, Hajek R. Maisnar V, et al. Among authors: hajek r. Clin Lymphoma Myeloma Leuk. 2023 Feb;23(2):145-153. doi: 10.1016/j.clml.2022.11.001. Epub 2022 Nov 6. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36567210
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling.
Turi M, Anilkumar Sithara A, Hofmanová L, Žihala D, Radhakrishnan D, Vdovin A, Knápková S, Ševčíková T, Chyra Z, Jelínek T, Šimíček M, Gullà A, Anderson KC, Hájek R, Hrdinka M. Turi M, et al. Among authors: hajek r. Int J Mol Sci. 2023 Mar 15;24(6):5623. doi: 10.3390/ijms24065623. Int J Mol Sci. 2023. PMID: 36982699 Free PMC article.
Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis.
Lachnit M, Revendova KZ, Hradilek P, Bunganic R, Koristek Z, Jelinek T, Skutova M, Piza R, Volny O, Hajek R, Bar M. Lachnit M, et al. Among authors: hajek r. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Mar;168(1):50-54. doi: 10.5507/bp.2023.023. Epub 2023 Jun 16. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024. PMID: 37337857 Free article.
Length-Dependent Translation Efficiency of ER-Destined Proteins.
Sahinbegovic H, Vdovin A, Snaurova R, Durech M, Nezval J, Sobotka J, Hajek R, Jelinek T, Simicek M. Sahinbegovic H, et al. Among authors: hajek r. Curr Issues Mol Biol. 2023 Aug 14;45(8):6717-6727. doi: 10.3390/cimb45080425. Curr Issues Mol Biol. 2023. PMID: 37623244 Free PMC article.
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID-19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic.
Šušol O, Šušolová B, Klempíř O, Navrátil M, Gumulec J, Kořístek Z, Ďuraš J, Kaščák M, Mihályová J, Stejskal L, Jelínek T, Richterová P, Szeligová L, Plonková H, Zuchnická J, Dluhošová B, Demel I, Buffa D, Hradská K, Popková T, Muroňová L, Lachnit M, Lančová K, Hájek R. Šušol O, et al. Among authors: hajek r. Cancer Med. 2024 Dec;13(24):e70503. doi: 10.1002/cam4.70503. Cancer Med. 2024. PMID: 39711119 Free PMC article.
598 results